Nonclassical 3β-hydroxysteroid dehydrogenase deficiency: a review of our experience with 25 female patients**Supported by United States Public Health Service, National Institutes of Health, Bethesda, Maryland, grant awards HD00072 and RR 06020. Support was also received from the United Jewish Appeal: Federation of Jewish Philantrophies of New York, Inc; and the Reichman Family Fund (Olympia and York [US] Holdings Co., New York New York).††Presented in part at the 72nd Annual Meeting of The Endocrine Society, Atlanta, Georgia, June 20 to 23, 1990.